Enhanced Games’ Big Gamble Backfires: Parent Company Loses Over $60 Million

The Enhanced Games was supposed to be the boldest experiment in modern sports: a competition where athletes could openly use performance-enhancing drugs, with no bans, no suspensions and no apologies. In theory, it was the kind of spectacle that would pull in millions of curious viewers and force a global conversation about the limits of human performance.

In practice, it was a financial disaster.

The company behind the event, Enhanced Group, disclosed a Q2 2026 net loss of about $61.9 million, and most of that red ink was tied to the costs of producing the games. The event had been promoted heavily across social media, and it was available to watch for free on multiple streams. That still was not enough to get people to tune in.

The Enhanced Group is not, at its core, an events company. It runs a telehealth platform that sells FDA-approved treatments, including peptides, testosterone and GLP-1 weight-loss drugs. In Q2, though, most of its $17.7 million in revenue came from game sponsorships rather than that core business. That says a lot about how much the company had staked on the games becoming a cultural moment.

The deeper problem may be structural. The best athletes in the world, even those who have used performance-enhancing drugs, are not eager to stand up and claim a ‘steroid Olympics’ as their stage. Doping still carries a stigma, and every major sports federation still tests its athletes. So the talent pool that actually showed up was, at best, a mix of mediocre and above-average athletes willing to use PEDs. Only one world record was broken, in swimming, a sport where records fall fairly regularly anyway.

That left the Enhanced Games in a strange position: controversial enough to generate headlines, but not credible enough to hold an audience. The original plan had been to make it an annual event. Now, those plans are in doubt. The company recently announced ‘Enhanced Breakers,’ a smaller online series designed to keep athletes and sponsors engaged without the expense of another full-scale games.

There is a brighter spot for the parent company, though. The FDA recently reclassified several peptide substances that had been sitting in a legal gray area, which suggests a friendlier regulatory environment for the telehealth business. That matters because Enhanced Group’s long-term survival likely depends less on the games and more on the treatments it sells online.

If there is a lesson here, it is that shock value only takes an idea so far. Without elite talent willing to participate, the on-field product cannot compete with the Olympics or any other major sporting event. Enhanced Group may still find a path forward in telehealth, but the failed games offer a clear reminder that attention and credibility are not the same thing.

This story was originally published by Men's Fitness on Aug 22, 2026, where it first appeared in the News section. Add Men's Fitness as a Preferred Source by clicking here.